tiprankstipranks
Trending News
More News >
Viridian Therapeutics (VRDN)
NASDAQ:VRDN
US Market

Viridian Therapeutics (VRDN) Income Statement

Compare
1,441 Followers

Viridian Therapeutics Income Statement

Last quarter (Q3 2025), Viridian Therapeutics's total revenue was $70.57M, an increase of 81958.14% from the same quarter last year. In Q3, Viridian Therapeutics's net income was $-34.60M. See Viridian Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 302.00K$ 314.00K$ 1.77M$ 2.96M$ 1.05M
Gross Profit
$ 302.00K$ 314.00K$ 1.77M$ 2.96M$ -27.25M
Operating Expenses
$ 299.34M$ 254.76M$ 136.08M$ 82.69M$ 83.13M
Depreciation and Amortization
$ 1.24M$ 522.00K$ 255.00K$ 120.00K$ 239.00K
EBITDA
$ -265.66M$ -235.37M$ -129.13M$ -79.29M$ -40.28M
Operating Income
$ -299.04M$ -254.45M$ -134.30M$ -79.73M$ -110.38M
Other Income/Expenses
$ 29.09M$ 16.72M$ 4.43M$ 315.00K$ -335.00K
Pretax Income
$ -269.95M$ -237.73M$ -129.87M$ -79.41M$ -110.72M
Net Income
$ -269.95M$ -237.73M$ -129.87M$ -79.41M$ -110.72M
Per Share Metrics
Basic EPS
$ -3.98$ -5.31$ -3.91$ -6.66$ -31.20
Diluted EPS
$ -3.98$ -5.31$ -3.91$ -6.66$ -31.20
Weighted Average Shares Outstanding
67.89M 44.76M 32.09M 11.92M 3.56M
Weighted Average Shares Outstanding (Diluted)
67.89M 44.76M 32.09M 11.92M 3.56M
Currency in USD

Viridian Therapeutics Earnings and Revenue History